Cutter Capital Management, LP

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001983313
Type: FundHoldings: 21Value: $229.6MLatest: 2025Q1

Cutter Capital Management, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 21 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
21
Total Value
229647548
Accession Number
0001214659-25-007818
Form Type
13F-HR
Manager Name
Cutter-Capital-Management-Lp
Data Enrichment
100% identified
21 identified0 unidentified

Holdings

21 positions • $229.6M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
BRISTOL MYERS SQUIBB CO
Shares:295.0K
Value:$18.0M
% of Portfolio:7.8% ($18.0M/$229.6M)
AMGEN INC
Shares:50.0K
Value:$15.6M
% of Portfolio:6.8% ($15.6M/$229.6M)
BIOGEN INC.
Shares:113.5K
Value:$15.5M
% of Portfolio:6.8% ($15.5M/$229.6M)
ELI LILLY & Co
Shares:18.0K
Value:$14.9M
% of Portfolio:6.5% ($14.9M/$229.6M)
INSMED Inc
Shares:186.4K
Value:$14.2M
% of Portfolio:6.2% ($14.2M/$229.6M)
Ultragenyx Pharmaceutical Inc.
Shares:379.3K
Value:$13.7M
% of Portfolio:6.0% ($13.7M/$229.6M)
BridgeBio Pharma, Inc.
Shares:390.6K
Value:$13.5M
% of Portfolio:5.9% ($13.5M/$229.6M)
PERRIGO Co plc
Shares:479.5K
Value:$13.4M
% of Portfolio:5.9% ($13.4M/$229.6M)
Roivant Sciences Ltd.
Shares:1.3M
Value:$13.1M
% of Portfolio:5.7% ($13.1M/$229.6M)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shares:801.8K
Value:$12.3M
% of Portfolio:5.4% ($12.3M/$229.6M)
Royalty Pharma plc
Shares:356.9K
Value:$11.1M
% of Portfolio:4.8% ($11.1M/$229.6M)
Tarsus Pharmaceuticals, Inc.
Shares:205.0K
Value:$10.5M
% of Portfolio:4.6% ($10.5M/$229.6M)
Verona Pharma plc
Shares:160.0K
Value:$10.2M
% of Portfolio:4.4% ($10.2M/$229.6M)
MADRIGAL PHARMACEUTICALS, INC.
Shares:24.0K
Value:$7.9M
% of Portfolio:3.5% ($7.9M/$229.6M)
Summit Therapeutics Inc.
Shares:400.0K
Value:$7.7M
% of Portfolio:3.4% ($7.7M/$229.6M)
HALOZYME THERAPEUTICS, INC.
Shares:120.0K
Value:$7.7M
% of Portfolio:3.3% ($7.7M/$229.6M)
CYTOKINETICS INC
Shares:175.0K
Value:$7.0M
% of Portfolio:3.1% ($7.0M/$229.6M)
AGIOS PHARMACEUTICALS, INC.
Shares:235.3K
Value:$6.9M
% of Portfolio:3.0% ($6.9M/$229.6M)
Centessa Pharmaceuticals plc
Shares:418.1K
Value:$6.0M
% of Portfolio:2.6% ($6.0M/$229.6M)
Arcus Biosciences, Inc.
Shares:731.8K
Value:$5.7M
% of Portfolio:2.5% ($5.7M/$229.6M)